Search

everythinglearnresearchcommunity

for

Search:↓

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Nilotinib can cause generalized keratosis pilaris.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Gefitinib can cause rare scarring hair loss.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Natural products can help overcome cancer drug resistance.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.